LIQT vs PRZO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LIQT exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. The company suffers from deep operational inefficiency with an operating margin of -85.77% and negative revenue growth (-8.20% YoY). Despite a strong current ratio of 3.38 providing a short-term liquidity cushion, the long-term trajectory is catastrophic, evidenced by a 97.3% decline in share price over five years. The lack of profitability and consistent earnings misses render the stock a high-risk speculative asset.
PRZO exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a catastrophic operating margin of -565.59%. While the company maintains a strong current ratio (3.64) and low debt-to-equity (0.10), these liquidity metrics are overshadowed by a lack of profitability and a Price/Sales ratio of 16.17, which is unjustifiable given the 0% profit margin. The technical trend is completely bearish (0/100), and the stock has lost 81% of its value over the last five years, indicating a failure to scale its technology into a viable business model.
Compare Another Pair
Related Comparisons
LIQT vs PRZO: Head-to-Head Comparison
This page compares LiqTech International, Inc. (LIQT) and ParaZero Technologies Ltd. (PRZO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.